Talk to a Nurse 1-888-841-MMRF(6673) (Monday - Friday, 9am - 7pm ET)
The International Myeloma Workshop (IMW) 2019

The MMRF will be in Boston for IMW 2019 at

Booth #1021

 

The International Myeloma Workshop (IMW) 2019

September 12 – 15: Hynes Convention Center, Boston, MA

IMW is held every 2 years and is devoted to fostering scientific and clinical exchange on the latest breakthroughs in multiple myeloma and related plasma cell disorders.

The MMRF will be presenting abstracts, daily webinar updates, daily social media posts, and a patient symposium. 

View our press release

Join us online:

MMRF Patient Symposium at IMW 2019

Sunday, September 15: 12:00 - 3:30pm EDT

Drs. Irene Ghobrial (Dana-Farber Cancer Institute), Maria Mateos (University of Salamanca, Spain), Paul Richardson (Dana-Farber Cancer Institute), and Jesus San Miguel (University of Navarra, Spain) will discuss the latest information on treatment options for multiple myeloma.

Register

Facebook Live

On Thursday, Friday and Saturday the MMRF will be live on Facebook with myeloma experts covering topics from the workshops. Join us LIVE!

Featuring Time
Paul Richardson and Irene Ghobrial Thursday, 9/12 - 5:30pm EDT  
Amrita Krishnan and Jesus Berdeja Friday, 9/13 - 12:30pm EDT  
Shaji Kumar and Noopur Raje Saturday, 9/14 - 4:00 pm EDT  

IMW Daily Webinar Updates

Join the MMRF and our partners at IMW 2019 to hear the latest clinical information via our daily webinar updates.

Thursday, September 12
Drs. Irene Ghobrial and Paul Richardson from Dana-Farber Cancer Institute will discuss the latest clinical updates on smoldering multiple myeloma, myeloma diagnosis, and disease management.


Friday, September 13
Drs. Jesus Berdeja, Sarah Cannon Research Institute and Amrita Krishnan, City of Hope Medical Center will discuss treatment for newly diagnosed multiple myeloma and immunotherapy advances.


Saturday, September 14
Drs. Shaji Kumar, Mayo Clinic Rochester and Noopur Raje, Massachusetts General Hospital will focus on clinical updates regarding bone disease and treatment of relapsed/refractory multiple myeloma.

Register

Follow us during IMW:

Left Menu Icon